“john-crowley” Archives

in
Entry Author Date Location
Amicus Offers First Look At Gene Therapy Work With Batten’s Data 08/01/19 New York
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy 04/15/19 National
Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals 08/10/18 New York
Amicus Therapeutics’ Pompe Drug Data Show Improved Muscle Movement 10/04/17 New York
Amicus Takes Aim at Rare Brain Disorder with MiaMed Acquisition 07/06/16 New York
Amicus Nabs First Approval as EU Gives Green Light to Fabry Drug 05/31/16 New York
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
With Data in Hand, Amicus Preps For Drug Filings in U.S., Europe 03/19/15 New York
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
With Persistence And Phase 3 Win, Amicus Nears First Drug Approval 08/20/14 New York
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
Standing on a Ledge Once Again, Amicus Holds Breath for Latest Study 08/11/14 New York
Amicus Wheels, Deals, Restructures Following Fabry Drug Setback 11/20/13 New York
Amicus, Biogen Team Up on Parkinson’s Drug Deal 09/10/13 Boston
East Coast Life Sciences Roundup: IPO Madness, Amicus, & More 06/21/13 Boston
Amicus Shelves New-Drug Filing For Fabry Disease Drug 06/17/13 New York
Disease Foundations Play Growing Role in Biotech Business Model 03/06/12 San Francisco
Amicus Counts on “Chaperone” Tech to Enhance Rare Disease Treatments 01/11/12 New York
Page 1 of 1